GW24-e0244 The changes of heart function and NT-proBNP after advanced echo-guided cardiac resynchronisation therapy in patients with heart failure

Heart ◽  
2013 ◽  
Vol 99 (Suppl 3) ◽  
pp. A222.1-A222
Author(s):  
Guang Xue-feng ◽  
Dai Hai-long ◽  
Zuo Ming-xian ◽  
Gai Qi-ming ◽  
Ding Cheng-yan ◽  
...  
Keyword(s):  
Heart Failure ◽  
Heart Function ◽  
Cardiac Resynchronisation Therapy ◽  
Patients With Heart Failure ◽  
Cardiac Resynchronisation ◽  
Resynchronisation Therapy

Retrospective application of Program to Access and Review Trending iNformation and Evaluate coRrelation to Symptoms in patients with Heart Failure criteria for the remote management of patients with cardiac resynchronisation therapy

2016 ◽  
Vol 23 (4) ◽  
pp. 470-475
Author(s):  
Francesco MA Brasca ◽  
Jessica Franzetti ◽  
Valeria Rella ◽  
Gabriella Malfatto ◽  
Roberto Brambilla ◽  
...  
Keyword(s):  
Heart Failure ◽  
Remote Monitoring ◽  
Area Under The Curve ◽  
Cardiac Resynchronisation Therapy ◽  
Failure Criteria ◽  
Heart Failure Patients ◽  
Patients With Heart Failure ◽  
Cardiac Resynchronisation ◽  
Acute Decompensation ◽  
Resynchronisation Therapy

Aim The Program to Access and Review Trending iNformation and Evaluate coRrelation to Symptoms in patients with Heart Failure (PARTNERS HF) trial elaborated a multiparametric model for prediction of acute decompensation in advanced heart failure patients, based on periodical in office data download from cardiac resynchronisation devices. In this study, we evaluated the ability of the PARTNERS HF criteria to detect initial decompensation in a population of moderate heart failure patients under remote monitoring. Methods We retrospectively applied the PARTNERS HF criteria to 1860 transmissions from 104 patients (median follow up 21 months; range 1–67 months), who were enrolled in our programme of telemedicine after cardiac resynchronisation therapy. We tested the ability of a score based on these criteria to predict any acute clinical decompensation occurring in the 15 days following a transmission. Results In 441 cases, acute heart failure was diagnosed after the index transmission. The area under the curve (AUC) of the score for the diagnosis of acute decompensation was 0.752 (confidence interval (CI) 95% 0.728–0.777). The best score cut-off was consistent with the results of PARTNERS HF: with a score ≥2, sensitivity was 75% and specificity 68%. The odds ratio for events was 6.24 (CI 95% 4.90–7.95; p < 0.001). Conclusions When retrospectively applied to remote monitoring transmissions and arranged in a score, PARTNERS HF criteria could identify HF patients who subsequently developed acute decompensation. These results warrant prospective studies applying PARTNERS HF criteria to remote monitoring.

scholarly journals 169-07: Long term changes in transmural dispersion of repolarisation in patients with heart failure after cardiac resynchronisation therapy- A prospective study

EP Europace ◽  
2016 ◽  
Vol 18 (suppl_1) ◽  
pp. i116-i116
Author(s):  
Bharatraj Banavalikar ◽  
V.k. Ajit Kumar ◽  
Anees Thajudeen ◽  
Narayanan Namboodiri ◽  
Krishna Kumar Nair ◽  
...  
Keyword(s):  
Heart Failure ◽  
Prospective Study ◽  
Cardiac Resynchronisation Therapy ◽  
Patients With Heart Failure ◽  
Cardiac Resynchronisation ◽  
Long Term Changes ◽  
Resynchronisation Therapy ◽  
Transmural Dispersion ◽  
A Prospective Study

Effects of cardiac resynchronisation therapy in patients with heart failure having a narrow QRS Complex enrolled in PROSPECT

Heart ◽  
2010 ◽  
Vol 96 (14) ◽  
pp. 1107-1113 ◽  
Author(s):  
R. J. van Bommel ◽  
J. Gorcsan ◽  
E. S. Chung ◽  
W. T. Abraham ◽  
F. T. Gjestvang ◽  
...  
Keyword(s):  
Heart Failure ◽  
Cardiac Resynchronisation Therapy ◽  
Qrs Complex ◽  
Narrow Qrs ◽  
Patients With Heart Failure ◽  
Cardiac Resynchronisation ◽  
Narrow Qrs Complex ◽  
Resynchronisation Therapy

scholarly journals Cardiac Resynchronisation Therapy and Heart Failure: Persepctive from 5P Medicine

2015 ◽  
Vol 1 (1) ◽  
pp. 35 ◽  
Author(s):  
Fang Fang ◽  
Zhou Yu Jie ◽  
Luo Xiu Xia ◽  
Liu Ming ◽  
Ma Zhan ◽  
...  
Keyword(s):  
Heart Failure ◽  
Cardiac Resynchronisation Therapy ◽  
Left Ventricular ◽  
Left Ventricular Ejection ◽  
Ventricular Ejection Fraction ◽  
Patients With Heart Failure ◽  
Cardiac Resynchronisation ◽  
Resynchronisation Therapy ◽  
Qrs Duration

Chronic heart failure is still a major challenge for healthcare. Currently, cardiac resynchronisation therapy (CRT) has been incorporated into the updated guideline for patients with heart failure, left ventricular ejection fraction ≤35 % and prolonged QRS duration. With 20 years of development, the concept of ‘from bench to bedside’ has been illustrated in the field of CRT. Given the fact that the indications of CRT keep evolving, the role of CRT is not limited to the curative method for heart failure. We therefore summarise with the perspective of 5P medicine – preventive, personalised, predictive, participatory, promotive, to review the benefit of CRT in the prevention of heart failure in those with conventional pacemaker indications, the individualised assessment of patient’s selection, the predictor of responders of CRT, and the obstacles hindering the more application of CRT and the future development of this device therapy.

scholarly journals Outcomes of cardiac resynchronisation therapy in patients with heart failure with atrial fibrillation: a systematic review and meta-analysis of observational studies

Open Heart ◽  
2019 ◽  
Vol 6 (1) ◽  
pp. e000937 ◽  
Author(s):  
Usman Mustafa ◽  
Jessica Atkins ◽  
George Mina ◽  
Desiree Dawson ◽  
Catherine Vanchiere ◽  
...  
Keyword(s):  
Heart Failure ◽  
Atrial Fibrillation ◽  
Cardiovascular Mortality ◽  
Observational Studies ◽  
Meta Analysis ◽  
Cardiac Resynchronisation Therapy ◽  
Patients With Heart Failure ◽  
Cardiac Resynchronisation ◽  
All Cause Mortality ◽  
Resynchronisation Therapy

BackgroundCardiac resynchronisation therapy (CRT) is beneficial in selected patients with heart failure (HF) in normal sinus rhythm (NSR). We sought to evaluate the impact of CRT with or without atrioventricular junction (AVJ) ablation in patients with HF with concomitant atrial fibrillation (AF)Methods and resultsLiterature was searched (inception through 30 August 2017) for observational studies that reported outcomes in patients with HF with CRT and AF that reported all-cause and cardiovascular mortality. Thirty-one studies with 83, 571 patients were included. CRT did not decrease mortality compared with internal cardioverter defibrillator or medical therapy alone in patients with HF and AF with indications for CRT (OR: 0.851, 95% CI 0.616 to 1.176, p=0.328, I2=86.954). CRT-AF patients had significantly higher all-cause and cardiovascular mortality than CRT-NSR patients ([OR: 1.472, 95% CI 1.301 to 1.664, p=0.000] and [OR: 1.857, 95% CI 1.350 to 2.554, p=0.000] respectively). Change in left ventricular ejection fraction was not different between CRT patients with and without AF (p=0.705). AVJ ablation, however, improved all-cause mortality in CRT-AF patients when compared with CRT-AF patients without AVJ ablation (OR: 0.485, 95% CI 0.247 to 0.952, p=0.035). With AVJ ablation, there was no difference in all-cause mortality in CRT-AF patients compared with CRT-NSR patients (OR: 1.245, 95% CI 0.914 to 1.696, p=0.165).ConclusionThe results of our meta-analysis suggest that AF was associated with decreased CRT benefits in patients with HF. CRT, however, benefits patients with AF with AVJ ablation.

scholarly journals EFFECT OF CARDIAC RESYNCHRONISATION THERAPY IN PATIENTS WITH HEART FAILURE AND RBBB

Heart ◽  
2012 ◽  
Vol 98 (Suppl 2) ◽  
pp. E224.1-E224
Author(s):  
Fu Yi ◽  
Bing Liu ◽  
Min Shen ◽  
Feng Wu ◽  
Jun Zhang ◽  
...  
Keyword(s):  
Heart Failure ◽  
Cardiac Resynchronisation Therapy ◽  
Patients With Heart Failure ◽  
Cardiac Resynchronisation ◽  
Resynchronisation Therapy
Sign in / Sign up

Export Citation Format

Share Document